Detalhe da pesquisa
1.
Metastatic Prostate Cancer: Treatment Options.
Oncology
; 100(1): 48-59, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781285
2.
Impact of 68Ga-PSMA-11 PET staging on clinical decision-making in patients with intermediate or high-risk prostate cancer.
Eur J Nucl Med Mol Imaging
; 47(3): 652-664, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31802175
3.
Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations.
World J Urol
; 38(3): 681-693, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31297628
4.
Imaging Diagnosis and Follow-up of Advanced Prostate Cancer: Clinical Perspectives and State of the Art.
Radiology
; 292(2): 273-286, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237493
5.
Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Eur J Nucl Med Mol Imaging
; 46(4): 889-900, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30488099
6.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510020
7.
Case of the month from the Cantonal Hospital, St Gallen, Switzerland: checkpoint inhibition for recurrent prostate cancer.
BJU Int
; 131(2): 173-176, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36468816
8.
Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.
Radiology
; 280(1): 151-60, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26807894
9.
Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics.
Cancer Metastasis Rev
; 33(2-3): 555-66, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24452758
10.
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients.
Br J Cancer
; 113(8): 1225-33, 2015 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26379078
11.
Simple prognostic score for metastatic castration-resistant prostate cancer with incorporation of neutrophil-to-lymphocyte ratio.
Cancer
; 120(21): 3346-52, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24995769
12.
Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study.
Invest New Drugs
; 32(5): 995-1004, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24771350
13.
The Advanced Prostate Cancer Consensus on a regional level - what can we learn?
BJU Int
; 123(1): 3-4, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30565404
14.
Randomized Phase II trial of nintedanib, afatinib and sequential combination in castration-resistant prostate cancer.
Future Oncol
; 10(2): 219-31, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24490608
15.
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.
Lancet Oncol
; 14(9): 882-92, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23810788
16.
Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland - A claims data analysis.
Eur J Cancer
; 204: 114072, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678761
17.
Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot Study.
Cardiovasc Intervent Radiol
; 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38416176
18.
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel)
; 16(8)2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38672547
19.
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.
Cancer Epidemiol Biomarkers Prev
; 33(3): 419-425, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189661
20.
T-cell activation by treatment of cancer patients with EMD 521873 (Selectikine), an IL-2/anti-DNA fusion protein.
J Transl Med
; 11: 5, 2013 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23294527